Joseph DiMasi : Citation Profile

Are you Joseph DiMasi?

6

H index

5

i10 index

652

Citations

RESEARCH PRODUCTION:

11

Articles

4

Papers

RESEARCH ACTIVITY:

   28 years (1988 - 2016). See details.
   Cites by year: 23
   Journals where Joseph DiMasi has often published
   Relations with other researchers
   Recent citing documents: 68.    Total self citations: 5 (0.76 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pdi386
   Updated: 2023-03-25    RAS profile: 2016-05-25    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Joseph DiMasi.

Is cited by:

Siebert, Ralph (14)

Banerjee, Tannista (11)

Magazzini, Laura (9)

Versaevel, Bruno (9)

Pertile, Paolo (8)

Pammolli, Fabio (8)

La Croix, Sumner (8)

Dosis, Anastasios (8)

Muthoo, Abhinay (8)

Boldrin, Michele (7)

Gamba, Simona (7)

Cites to:

Lichtenberg, Frank (2)

Fama, Eugene (1)

Cockburn, Iain (1)

Olson, Mary (1)

Newhouse, Joseph (1)

Harvey, Campbell (1)

French, Kenneth (1)

Philipson, Tomas (1)

Culyer, Anthony (1)

Main data

Where Joseph DiMasi has published?

Journals with more than one article published# docs
Journal of Health Economics5
Managerial and Decision Economics2

Working Papers Series with more than one paper published# docs
Working Papers / Duke University, Department of Economics2

Recent works citing Joseph DiMasi (2022 and 2021)

YearTitle of citing document
2022The Internationalisation of the Large Brazilian Pharmaceutical Companies: Challenges, Competitive Advantages and Strategies. (2022). Paranhos, Julia ; Perin, Fernanda. In: CAFE Working Papers. RePEc:akf:cafewp:20.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2022.

Full description at Econpapers || Download paper

2023Optimal Experimental Design for Staggered Rollouts. (2019). Imbens, Guido ; Bayati, Mohsen ; Athey, Susan ; Xiong, Ruoxuan. In: Papers. RePEc:arx:papers:1911.03764.

Full description at Econpapers || Download paper

2021Product recalls, market size and innovation in the pharmaceutical industry. (2021). Morescalchi, Andrea ; Riccaboni, Massimo ; Nutarelli, Federico. In: Papers. RePEc:arx:papers:2111.15389.

Full description at Econpapers || Download paper

2022Awareness and use of quantitative decision-making methods in pharmaceutical development. (2022). Thommes, Guido ; Robert, Veronique ; Abellan, Juan J ; Carlton, Alex ; Bonnet, Nicolas ; Sailer, Martin Oliver. In: Papers. RePEc:arx:papers:2203.00684.

Full description at Econpapers || Download paper

2022When Will the FDA Do What Is in People’s Best Interests?. (2022). Ordman, Alfred B. In: American Journal of Economics and Sociology. RePEc:bla:ajecsc:v:81:y:2022:i:4:p:721-751.

Full description at Econpapers || Download paper

2022Do Mandatory Disclosure Requirements for Private Firms Increase the Propensity of Going Public?. (2022). Thakor, Richard ; Aghamolla, Cyrus. In: Journal of Accounting Research. RePEc:bla:joares:v:60:y:2022:i:3:p:755-804.

Full description at Econpapers || Download paper

2021Strategic Decision Making in the Digital Age: Expert Sentiment and Corporate Capital Allocation. (2021). Raisch, Sebastian ; Luger, Johannes ; Nauhaus, Steffen . In: Journal of Management Studies. RePEc:bla:jomstd:v:58:y:2021:i:7:p:1933-1961.

Full description at Econpapers || Download paper

2021Collaboration in Development of New Drugs. (2021). Xu, YI ; Gurnani, Haresh ; Tian, Zhili. In: Production and Operations Management. RePEc:bla:popmgt:v:30:y:2021:i:11:p:3943-3966.

Full description at Econpapers || Download paper

2021Efficient industrial policy for innovation: standing on the shoulders of hidden giants. (2021). Mohnen, Pierre ; Verhoeven, Dennis ; Thomas, Catherine ; Martin, Ralf ; Guillard, Charlotte. In: CEP Discussion Papers. RePEc:cep:cepdps:dp1813.

Full description at Econpapers || Download paper

2021Medical Innovations and Ageing: A Health Economics Perspective. (2021). Grossmann, Volker. In: CESifo Working Paper Series. RePEc:ces:ceswps:_9387.

Full description at Econpapers || Download paper

2021Centrality analysis in a drug network and its application to drug repositioning. (2021). Ratnavelu, Kurunathan ; Kwa, Kiam Heong ; Keng, Ying Ying. In: Applied Mathematics and Computation. RePEc:eee:apmaco:v:395:y:2021:i:c:s0096300320308237.

Full description at Econpapers || Download paper

2022Incentives for pharmaceutical innovation: What’s working, what’s lacking. (2022). Kyle, Margaret K. In: International Journal of Industrial Organization. RePEc:eee:indorg:v:84:y:2022:i:c:s0167718722000261.

Full description at Econpapers || Download paper

2022Impact of stronger intellectual property rights regime on innovation: Evidence from de alio versus de novo Indian bio-pharmaceutical firms. (2022). Wernz, Christian ; Thakurwernz, Pooja. In: Journal of Business Research. RePEc:eee:jbrese:v:138:y:2022:i:c:p:457-473.

Full description at Econpapers || Download paper

2022Innovation and misconduct in the pharmaceutical industry. (2022). Stewart, Oscar Jerome ; Troyer, Jennifer L ; Amato, Louis H ; Arnold, Denis G. In: Journal of Business Research. RePEc:eee:jbrese:v:144:y:2022:i:c:p:1052-1063.

Full description at Econpapers || Download paper

2022Discovery sells, but who’s buying? An empirical investigation of entrepreneurs’ technology license decisions. (2022). Scheaf, David J ; Wood, Matthew S ; Brown, Austin R. In: Journal of Business Research. RePEc:eee:jbrese:v:144:y:2022:i:c:p:403-415.

Full description at Econpapers || Download paper

2022Sourcing portfolio diversity in new product development: Antecedents and performance implications. (2022). Contractor, Farok ; Bruyaka, Olga ; Thakur-Wernz, Pooja. In: Journal of Business Research. RePEc:eee:jbrese:v:150:y:2022:i:c:p:179-193.

Full description at Econpapers || Download paper

2022IPO peer effects. (2022). Thakor, Richard ; Aghamolla, Cyrus. In: Journal of Financial Economics. RePEc:eee:jfinec:v:144:y:2022:i:1:p:206-226.

Full description at Econpapers || Download paper

2021R&D and market size: Who benefits from orphan drug legislation?. (2021). Pertile, Paolo ; Gamba, Simona ; Magazzini, Laura. In: Journal of Health Economics. RePEc:eee:jhecon:v:80:y:2021:i:c:s0167629621001077.

Full description at Econpapers || Download paper

2022The economics of medical procedure innovation. (2022). Dranove, David ; Wu, Bingxiao ; Heard, Christopher ; Garthwaite, Craig. In: Journal of Health Economics. RePEc:eee:jhecon:v:81:y:2022:i:c:s016762962100134x.

Full description at Econpapers || Download paper

2021Strategic green technology innovation in a two-stage alliance: Vertical collaboration or co-development?. (2021). Lan, Yanfei ; Yu, Xinning ; Zhao, Ruiqing. In: Omega. RePEc:eee:jomega:v:98:y:2021:i:c:s0305048318312040.

Full description at Econpapers || Download paper

2021COVID-19 vaccine rollout—scale and speed carry different implications for corruption. (2021). Nelson, Michael ; Goel, Rajeev. In: Journal of Policy Modeling. RePEc:eee:jpolmo:v:43:y:2021:i:3:p:503-520.

Full description at Econpapers || Download paper

2021Measuring the connectedness of global health sector stock markets. (2021). Geng, Jiang-Bo ; Ye, Liping. In: Pacific-Basin Finance Journal. RePEc:eee:pacfin:v:68:y:2021:i:c:s0927538x21001220.

Full description at Econpapers || Download paper

2021The fall of the innovation empire and its possible rise through open science. (2021). Gold, Richard E. In: Research Policy. RePEc:eee:respol:v:50:y:2021:i:5:s0048733321000305.

Full description at Econpapers || Download paper

2022Generic competition and the incentives for early-stage pharmaceutical innovation. (2022). Higgins, Matthew J ; Chatterjee, Chirantan ; Branstetter, Lee. In: Research Policy. RePEc:eee:respol:v:51:y:2022:i:10:s0048733322001184.

Full description at Econpapers || Download paper

2021Product patents and access to innovative medicines. (2021). Watal, Jayashree ; Dai, Rong. In: Social Science & Medicine. RePEc:eee:socmed:v:291:y:2021:i:c:s027795362100811x.

Full description at Econpapers || Download paper

2022Absorbing knowledge from an emerging field: The role of interfacing by proponents in big pharma. (2022). , Iwan ; van der Sijde, Peter. In: Technovation. RePEc:eee:techno:v:110:y:2022:i:c:s0166497221001449.

Full description at Econpapers || Download paper

2022Screening ideas in the early stages of technology development: A word2vec and convolutional neural network approach. (2022). Lee, Changyong ; Kim, Young-Choon ; Woo, Han-Gyun ; Hong, Suck Won. In: Technovation. RePEc:eee:techno:v:112:y:2022:i:c:s0166497221001887.

Full description at Econpapers || Download paper

2022Regulatory review of new product innovation: Conceptual clarity and future research directions. (2022). Mordi, Chima ; Sarpong, David ; Boakye, Derrick. In: Technological Forecasting and Social Change. RePEc:eee:tefoso:v:175:y:2022:i:c:s0040162521008507.

Full description at Econpapers || Download paper

2021Efficient industrial policy for innovation: standing on the shoulders of hidden giants. (2021). Verhoeven, Dennis ; Thomas, Catherine ; Martin, Ralf ; Guillard, Charlotte. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:113832.

Full description at Econpapers || Download paper

2021The Effect of Financial Risk Taking on Profitability in the Pharmaceutical Industry. (2021). Martha, Bernadett Beresne ; Lakatos, Vilmos ; Tomori, Gerg. In: Economies. RePEc:gam:jecomi:v:9:y:2021:i:4:p:153-:d:655754.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2022.

Full description at Econpapers || Download paper

2022.

Full description at Econpapers || Download paper

2022.

Full description at Econpapers || Download paper

2022A New Digital Value Chain Model with PLC in Biopharmaceutical Industry: The Implication for Open Innovation. (2022). Atukeren, Erdal ; Kim, Yongchan ; Lee, Yeonwoo. In: JOItmC. RePEc:gam:joitmc:v:8:y:2022:i:2:p:63-:d:783144.

Full description at Econpapers || Download paper

2021Determinants of Internationalization as Levers for Sustainability: A Study of the Portuguese Pharmaceutical Sector. (2021). Ascenso, Raquel ; Frade, Rui ; Vieira, Jorge ; Martinho, Domingos. In: Sustainability. RePEc:gam:jsusta:v:13:y:2021:i:17:p:9792-:d:626308.

Full description at Econpapers || Download paper

2021Communication for Open Innovation in Japanese Drug Discovery Ventures. (2021). Tomita, Kenji. In: Journal of Management Sciences. RePEc:gei:journl:v:8:y:2021:i:1:p:36-49.

Full description at Econpapers || Download paper

2021Rushed Innovation: Evidence from Drug Licensing. (2021). Hermosilla, Manuel. In: Management Science. RePEc:inm:ormnsc:v:67:y:2021:i:1:p:257-278.

Full description at Econpapers || Download paper

2021Inducing Compliance with Postmarket Studies for Drugs Under FDA’s Accelerated Approval Pathway. (2021). Petruzzi, Nicholas C ; Zhao, Hui ; Xu, Liang. In: Manufacturing & Service Operations Management. RePEc:inm:ormsom:v:23:y:2021:i:1:p:170-190.

Full description at Econpapers || Download paper

2021Do companies in the pharmaceutical supply chain earn excess returns?. (2021). Sood, Neeraj ; Mulligan, Karen ; Zhong, Kimberly. In: International Journal of Health Economics and Management. RePEc:kap:ijhcfe:v:21:y:2021:i:1:d:10.1007_s10754-020-09291-1.

Full description at Econpapers || Download paper

2021Microgravity protein crystallization for drug development: a bold example of public sector entrepreneurship. (2021). Vonortas, Nicholas S ; Scott, Troy J. In: The Journal of Technology Transfer. RePEc:kap:jtecht:v:46:y:2021:i:5:d:10.1007_s10961-019-09743-y.

Full description at Econpapers || Download paper

2022“The theory of economic regulation” after 50 years. (2022). Peltzman, Sam . In: Public Choice. RePEc:kap:pubcho:v:193:y:2022:i:1:d:10.1007_s11127-022-00996-0.

Full description at Econpapers || Download paper

2022Capture and passive predation in times of COVID-19 pandemic. (2022). Guennif, Samira. In: Public Choice. RePEc:kap:pubcho:v:193:y:2022:i:3:d:10.1007_s11127-022-01005-0.

Full description at Econpapers || Download paper

2021Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions. (2021). Bennato, Anna Rita ; Mariuzzo, Franco. In: Small Business Economics. RePEc:kap:sbusec:v:57:y:2021:i:1:d:10.1007_s11187-019-00307-w.

Full description at Econpapers || Download paper

2021A unified drug–target interaction prediction framework based on knowledge graph and recommendation system. (2021). Hou, Tingjun ; He, Shibo ; Cao, Dongsheng ; Chen, Jiming ; Kang, YU ; Yang, Ziyi ; Hsieh, Chang-Yu ; Ye, Qing. In: Nature Communications. RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-27137-3.

Full description at Econpapers || Download paper

2021The Economics of Medical Procedure Innovation. (2021). Dranove, David ; Wu, Bingxiao ; Heard, Christopher ; Garthwaite, Craig. In: NBER Working Papers. RePEc:nbr:nberwo:29438.

Full description at Econpapers || Download paper

2022Profitability and drug discovery. (2022). Orhangazi, Zgr ; Iak, Enes. In: Industrial and Corporate Change. RePEc:oup:indcch:v:31:y:2022:i:4:p:891-904..

Full description at Econpapers || Download paper

2021Comparing long-term value creation after biotech and non-biotech IPOs, 1997–2016. (2021). Ledley, Fred D ; Fitzgerald, Liam ; Holden, Jeremy ; de Boer, Skyler ; McNamee, Laura M ; Cleary, Ekaterina Galkina. In: PLOS ONE. RePEc:plo:pone00:0243813.

Full description at Econpapers || Download paper

2022Patent term extensions and commercialization lags in the pharmaceutical industry: A growth-theoretic analysis. (2022). Lai, Ching-Chong ; Lu, You-Xun ; Hu, Mei-Ying. In: MPRA Paper. RePEc:pra:mprapa:113923.

Full description at Econpapers || Download paper

2021Impact of public R&D as market matures: Evidence from solar PV industry. (2021). Jung, Hyejae ; Ryu, Hanee. In: Energy & Environment. RePEc:sae:engenv:v:32:y:2021:i:8:p:1543-1558.

Full description at Econpapers || Download paper

2022Access to Medicines and Medical Equipment during COVID-19: Searching Compatibility between the WTO and the WHO. (2022). Bharti, Nalin ; Fatma, Ayesha ; Kumar, Mrityunjay. In: India Quarterly: A Journal of International Affairs. RePEc:sae:indqtr:v:78:y:2022:i:1:p:68-87.

Full description at Econpapers || Download paper

2021Understanding the Trade-offs in Drug Development: Retrospective on Lessons from the Early Phase of the COVID-19 Pandemic. (2021). Vasuprada, T M ; Saha, Debdatta. In: Journal of Developing Societies. RePEc:sae:jodeso:v:37:y:2021:i:3:p:329-362.

Full description at Econpapers || Download paper

2021Rare Diseases Require Support Too. (2021). Das, Neelima ; Pingali, Viswanath . In: Vikalpa: The Journal for Decision Makers. RePEc:sae:vikjou:v:46:y:2021:i:2:p:129-134.

Full description at Econpapers || Download paper

2022Epic fail: Exploring project failure’s reasons, outcomes and indicators. (2022). Krezdorn, Nicco ; Herz, Marc. In: Review of Managerial Science. RePEc:spr:rvmgts:v:16:y:2022:i:4:d:10.1007_s11846-021-00479-4.

Full description at Econpapers || Download paper

2021Scientific publications from non-academic sectors and their impact. (2021). Baeta, Abilio Afonso ; McManus, Concepta ; Prata, Alvaro Toubes. In: Scientometrics. RePEc:spr:scient:v:126:y:2021:i:11:d:10.1007_s11192-021-04159-8.

Full description at Econpapers || Download paper

2021Innovation crisis in the pharmaceutical industry? A survey. (2021). Backfisch, Martin ; Laermann-Nguyen, Ute. In: SN Business & Economics. RePEc:spr:snbeco:v:1:y:2021:i:12:d:10.1007_s43546-021-00163-5.

Full description at Econpapers || Download paper

2022Clinical Trials with External Control: Beyond Propensity Score Matching. (2022). Fang, Yixin ; Wang, Hongwei ; Chen, SU. In: Statistics in Biosciences. RePEc:spr:stabio:v:14:y:2022:i:2:d:10.1007_s12561-022-09341-x.

Full description at Econpapers || Download paper

2021Do patents really foster innovation in the pharmaceutical sector? Results from an evolutionary, agent-based model. (2021). Dosi, Giovanni ; Russo, Emanuele ; Roventini, Andrea ; Palagi, Elisa. In: LEM Papers Series. RePEc:ssa:lemwps:2021/37.

Full description at Econpapers || Download paper

2022The Economic Value of Eliminating Diseases. (2022). Renneboog, Luc ; Kvarner, Jens ; Karpati, Daniel ; Crego, Julio. In: Discussion Paper. RePEc:tiu:tiucen:8b51764f-3ccd-4bb8-9da1-47a5ae26f01e.

Full description at Econpapers || Download paper

2022The Economic Value of Eliminating Diseases. (2022). Renneboog, Luc ; Kvarner, Jens ; Karpati, Daniel ; Crego, Julio. In: Other publications TiSEM. RePEc:tiu:tiutis:8b51764f-3ccd-4bb8-9da1-47a5ae26f01e.

Full description at Econpapers || Download paper

2022Bargaining and International Reference Pricing in the Pharmaceutical Industry. (2022). Vasserman, Shoshana ; Gandhi, Ashvin ; Dubois, Pierre. In: TSE Working Papers. RePEc:tse:wpaper:126993.

Full description at Econpapers || Download paper

2021Regulatory review time and pharmaceutical research and development. (2021). Bailey, James ; Chorniy, Anna ; Maloney, Michael ; Civan, Abdulkadir . In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:1:p:113-128.

Full description at Econpapers || Download paper

2021Do pharmaceutical prices rise anticipating branded competition?. (2021). Basu, Anirban ; Ellyson, Alice M. In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:5:p:1070-1081.

Full description at Econpapers || Download paper

2021Designing practical coordinating contracts in decentralized projects. (2021). Wagner, Michael R ; Klastorin, Ted ; Chen, Shi. In: Naval Research Logistics (NRL). RePEc:wly:navres:v:68:y:2021:i:2:p:183-198.

Full description at Econpapers || Download paper

2021The outsourcing conundrum: Misappropriation of intellectual property in supply chains. (2021). Chakravarty, Amiya K. In: Naval Research Logistics (NRL). RePEc:wly:navres:v:68:y:2021:i:2:p:229-240.

Full description at Econpapers || Download paper

2021The FDA and the COVID?19: A political economy perspective. (2021). March, Raymond J. In: Southern Economic Journal. RePEc:wly:soecon:v:87:y:2021:i:4:p:1210-1228.

Full description at Econpapers || Download paper

Works by Joseph DiMasi:

YearTitleTypeCited
2003Returns on R&D for 1990s New Drug Introductions In: Levine's Working Paper Archive.
[Full Text][Citation analysis]		paper2
2002Returns on R&D for 1990s New Drug Introductions.(2002) In: Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 2		paper
2003Returns on R&D for 1990s New Drug Introductions: Charts In: Levine's Working Paper Archive.
[Full Text][Citation analysis]		paper0
1995R&D Costs, Innovative Output and Firm Size in the Pharmaceutical Industry In: Working Papers.
[Citation analysis]		paper19
1995R&D Costs, Innovative Output and Firm Size in the Pharmaceutical Industry.(1995) In: International Journal of the Economics of Business.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 19		article
1991Cost of innovation in the pharmaceutical industry In: Journal of Health Economics.
[Full Text][Citation analysis]		article118
2003The price of innovation: new estimates of drug development costs In: Journal of Health Economics.
[Full Text][Citation analysis]		article341
2005Extraordinary claims require extraordinary evidence In: Journal of Health Economics.
[Full Text][Citation analysis]		article5
2005Setting the record straight on setting the record straight: Response to the Light and Warburton rejoinder In: Journal of Health Economics.
[Full Text][Citation analysis]		article4
2016Innovation in the pharmaceutical industry: New estimates of R&D costs In: Journal of Health Economics.
[Full Text][Citation analysis]		article129
1988Property tax classification and welfare in urban areas: A general equilibrium computational approach In: Journal of Urban Economics.
[Full Text][Citation analysis]		article1
2005The economics of follow-on drug research and development: Trends in entry rates and the timing of development — The authors’ reply In: PharmacoEconomics.
[Full Text][Citation analysis]		article1
2010Drug development costs when financial risk is measured using the Fama–French three?factor model In: Health Economics.
[Full Text][Citation analysis]		article9
2007Commentary In: Managerial and Decision Economics.
[Full Text][Citation analysis]		article0
2007The cost of biopharmaceutical R&D: is biotech different? In: Managerial and Decision Economics.
[Full Text][Citation analysis]		article23

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated March, 2 2023. Contact: CitEc Team